A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

Advocates for publicly funded coverage say there are detrimental and deadly health consequences for patients who cannot ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.